Acquisitions

BID Equity Fund II acquires analytics platform Carenity forging a new life science group with XClinical

EvidentIQ, 25 Jan 2021

BID Equity Fund II, a fund advised by BID Equity, acquires France-based Carenity, an anlytics platform supporting +500,000 patients and caregivers worldwide.

The acquisition enables BID Equity’s life science platform around software vendor XClinical to gain access to real-world patient data (RWD), digital solutions for patient recruitment, and feasibility studies.

With its innovative platform, Carenity delivers timely and compliant direct-to-patient research solutions to the life sciences industry that fuel the development of better medicines and services. Carenity’s social platform is available in France, UK, Italy, Germany, Spain and the US.

Previous

myneva Group acquires SWING to further strengthen its market-leading position in the social software sector

Next

Acquisition of US-based Fortress Medical Systems accelerates BID Equity‘s life science software group around German XClinical and French Carenity

More EvidentIQ News

04 Feb 2021

Acquisition of Fortress Medical Systems quickens BID Equity‘s life science software group around XClinical and Carenity.

12 Sep 2019

BID Equity Fund II, a fund advised by BID Equity, acquires a majority stake in XClinical GmbH. XClinical is a leading international provider of software solutions for drug and medical device studies.